Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2025 and 2025.
-
Busy address KBO
55 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Gimv Life Sciences Invest 2024 from Antwerpen, company number BE1019848694, closed financial year 2025 with a result of € -862,364 after tax. For that financial year Gimv Life Sciences Invest 2024 recorded a gross margin of € -159,001 and equity of € 15.6 million. Compared with financial year 2025, the result moved from € -25,022 to € -862,364. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 15.6 million
▲ € 15.2 million vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -862,364
▼ 3346 % more loss than in 2025
Profit after tax over the fiscal year.
€ 85,170
▲ 5% vs 2025
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -887,387.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 57,475
▲ € 50,975 vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 8,220
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2025 | 2025 | Change 2025 → 2025 | |
|---|---|---|---|
| Gross margin | € -21,827 | € -159,001 | ▼ € 137,173 |
| Profit after taxes | € -25,022 | € -862,364 | ▼ € 837,342 |
| Equity | € 374,978 | € 15,551,651 | ▲ € 15.2 million |
| Total debts | € 6,500 | € 65,695 | ▲ € 59,195 |
| Cash | € 81,277 | € 85,170 | ▲ 5% |
| Retained profit | € -25,022 | € -887,387 | ▼ € 862,364 |
| Balance sheet total | € 381,478 | € 15,617,346 | ▲ € 15.2 million |
Key figures of Gimv Life Sciences Invest 2024, fiscal years 2025 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Gimv Life Sciences Invest 2024?
What happened at Gimv Life Sciences Invest 2024 in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Koen Dejonckheere stepped down as director. NBB
- Edmond Bastijns stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 25,022. Source: NBB ↗
- Hawoka became a director. NBB
- Kristof Vande Capelle stepped down as director. NBB
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
- Kristof Vande Capelle became a director. NBB
In short
From € 25,022 loss in 2025 to € 862,364 loss in 2025.
A new publication or filing at Gimv Life Sciences Invest 2024? We notify you, reason included.
Follow Gimv Life Sciences Invest 2024Databakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Gimv Life Sciences Invest 2024 is Hawoka. The shares are held by Gimv 2024 Holding BV (99.3%), Gimv 2024 Poolco BV (0.5%), Gimv NV (0.2%) and . Derden (0%). It owns 10.9% of Kivu Bioscience Inc and 10.9% of Exciva GMBH itself.
Directors
According to the 2025 annual accounts
Director · represented by Kristof Vande Capelle
Also active at: ADVIESBEHEER GIMV HEALTH & CARE 2013, Adviesbeheer Gimv Connected Consumer 2013, ADVIESBEHEER GIMV SMART INDUSTRIES 2013, ADVIESBEHEER GIMV SUSTAINABLE CITIES 2013, TINC Manager, Adviesbeheer Gimv Smart Industries 2016, Adviesbeheer Gimv Connected Consumer 2016, Adviesbeheer Gimv Sustainable Cities 2016 +10 more
since 2025
Kristof Vande Capelle
Director
since 2025 · until 2025
Koen Dejonckheere
Director
since 2025 · until 2028
Director · represented by Edmond Bastijns
Also active at: ADVIESBEHEER GIMV HEALTH & CARE 2013, Adviesbeheer Gimv Connected Consumer 2013, ADVIESBEHEER GIMV SMART INDUSTRIES 2013, ADVIESBEHEER GIMV SUSTAINABLE CITIES 2013, Adviesbeheer Gimv Smart Industries 2016, Adviesbeheer Gimv Connected Consumer 2016, Adviesbeheer Gimv Sustainable Cities 2016, Adviesbeheer Gimv Health & Care 2016 +9 more
since 2025 · until 2028
Shareholders
Participations
Kivu Bioscience Inc
10.9%
Exciva GMBH
10.9%
Establishments
Establishment units
Physical locations of this company
Karel Oomsstraat 37
2018 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 55 companies are registered at this address.
All companies at this address →Gimv same network
€ 8.6 million revenue · 2025
Jan Moonen
€ 686,931 revenue · 2025
Wilson
€ 123,804 gross margin · 2025
San Michel
€ 64,813 gross margin · 2025
Immo Alfa
€ 383,148 gross margin · 2025
+50 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1019.848.694
- VAT number
- BE 1019.848.694
- Registered office
- Karel Oomsstraat 37, 2018 Antwerpen
- Names & denominations
- Gimv Life Sciences Invest 2024
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 February 2025
- Peppol
- Active · Active since 20 Apr 2026
- Activities · NACE
Activiteiten van holdings